DEferiprone Evaluation in Paediatrics (DEEP)
The project is aimed to study the efficacy and safety of deferiprone in children affected by β-thalassaemia major and other transfusion-dependent haemoglobinopathies.
ROLE OF THE FOUNDATION
The Foundation supported of the ethical and regulatory activities.
FUNDED BY: FP7-HEALTH-2010, GA 261483, 2011-16
DURATION: Jan 2011 - Aug 2016
www.cordis.europa.eu/project/id/261483
View all the project updates
DEEP: advancing Deferiprone use in paediatric thalassaemia
DEEP project open meeting: clinical research in Albania
DEEP-2 Clinical Trial: progress and updates newsletter
DEEP project assembly highlights paediatric iron overload progress
DEEP project: a success story in paediatrics and rare diseases